Skip to content
TrustList
Scalero logo
Person

Scalero

Lifecycle marketing agency offering email, automation and data services plus email-building tools

Scalero cover

About Scalero

Scalero is a lifecycle marketing studio that helps companies run email and customer-journey programmes. It works across common marketing automation and customer data platforms and can either add capacity to an existing team or build a programme from the start. It also makes its own software for producing email templates.

Services

  • Email marketing: content, design and coded emails using HTML, CSS and templating languages.
  • Marketing automation: set-up and improvement of automated journeys and segmentation.
  • Data engineering: data warehousing, modelling, customer data platform set-up and identity resolution.
  • SMS marketing: text-message campaigns alongside email.
  • Tiramisu and Cannoli: tools for organising email template projects and for exporting Figma designs to email-ready HTML.

Who it serves

Marketing teams at fast-growing brands. A customer quoted on the site is Vivino, a global business that uses the studio's app and team for campaign work.

Key facts

  • Platforms: Customer.io, Braze, Iterable, Klaviyo, Bloomreach and others
  • Products: Tiramisu and Cannoli

Profile written by TrustList from the business's own published information, Oct 2026.

Request a demo or quote from Scalero

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

By sending, you agree we may share your request and contact details with the provider once you confirm your email.

Reviews

Write the first review of Scalero

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Scalero.

Scalero alternatives

Similar listings buyers compare against this one.

Venture capital and venture-building arm of SCBX group focused on AI, blockchain and fintech

Incubation, investment and advisory firm helping emerging technologies reach Asian and US markets

Develops and commercialises cell therapies for neglected diseases with global innovators

Global alternative investment manager covering debt, venture capital and impact strategies with an Asia Pacific focus